Physicians Committee for Responsible Medicine
Washington D.C., District of Columbia, 20016, United States
NCT Number: NCT01699009
The purpose of the study is to assess whether, in individuals with migraines, a low-fat, vegan diet improves pain more effectively than a control supplement or a placebo. The principal measures are pain as measured by Visual Analog Scale (VAS) and the change in migraines frequency. The study duration is 36 weeks.This study also tests that a low fat, plant-based (vegan) diet free of foods commonly identified as triggers improves mood, using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R), and the Beck Depression Inventory II (BDI-II).
Looking for future studies?
Notify Me18 year–100 year
All sexes
Interventional
Not applicable
Washington D.C., District of Columbia, 20016, United States
Preliminary evidence suggests that low-fat, vegetarian diets and certain nutritional supplements can help reduce pain and also reduce the need for pain medications for some people. The investigators will ask about 100 people to participate. All of them will get a low-fat, vegan diet and a nutritional supplement (mixture of omega-3 oils and vitamin E or a placebo), although some will get the diet first, and others will get the supplement first. This order in which they will get the diet and the supplement will be determined randomly, that is, by chance (like the toss of a coin). The principal measures are pain as measured by Visual Analog Scale (VAS)and the change in migraines frequency.
Mood change will be measured using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R), and the Beck Depression Inventory II (BDI-II).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
A diagnosis of migraine, as defined by the criteria of the second edition of the International Classification of Headache Disorders:
At least 5 attacks fulfilling criteria the criteria below:
Exclusion criteria
Time frame: Baseline and 4 months
Pain as measured by VAS score
Time frame: Baseline and 4 months
the reduction in the number of migraine attacks.
Time frame: Baseline and 4 months
mood changes will be measured using the Beck Depression Inventory II (BDI-II).
Time frame: Baseline and 4 months
Mood changes will be measured using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R).
Time frame: Baseline and 4 months
Health related quality of life as measured by a questionnaire
Physicians Committee for Responsible Medicine
Other
Acronym: WCCR-MIG2
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03844412
Back Pain, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT06022848
Brain Diseases, Central Nervous System Diseases
London, United Kingdom
View Trial DetailsNCT01431326
Adenoviridae Infections, Adenovirus
Anchorage, Alaska, United States
View Trial DetailsNCT02748577
Brain Diseases, Central Nervous System Diseases
Winston-Salem, North Carolina, United States
View Trial Details